What inherited genetic disorders cause malabsorption leading to failure to thrive?

Genetic Causes of Malabsorption with Failure to Thrive

The primary inherited genetic disorders causing malabsorption and failure to thrive include cystic fibrosis (most common), congenital diarrhea and enteropathies (CODEs), and inherited disorders of intestinal lipid metabolism.

Major Genetic Disorders to Consider

Cystic Fibrosis (Most Common)

Cystic fibrosis is the most prevalent genetic cause of malabsorption leading to failure to thrive, occurring in approximately 1 in 3,500 white births in Europe 1. The CFTR gene mutation causes:

• Pancreatic insufficiency in 85-90% of patients, with up to 80% of dietary fat excreted in stools during infancy due to lipase deficiency 1
• Malabsorption resulting from insufficient pancreatic enzyme delivery to the intestinal lumen
• Energy losses compounded by high resting energy expenditure
• Fat-soluble vitamin deficiencies (A, D, E, K)

Early diagnosis through newborn screening is critical as it allows immediate intervention to minimize nutritional deficits and is associated with positive nutritional outcomes 1. Infants identified with CF benefit from pancreatic enzyme replacement therapy (PERT), high-calorie/high-fat diet, and fat-soluble vitamin supplementation 1.

Congenital Diarrhea and Enteropathies (CODEs)

These rare genetic disorders present with severe watery diarrhea, steatorrhea, dehydration, and poor growth in the neonatal period or early infancy 2. Key entities include:

Structural Intestinal Defects:

• Microvillus inclusion disease (MVID) - defective intestinal architecture
• Congenital tufting enteropathy (CTE) - abnormal epithelial tufts
• Both require histology/electron microscopy for diagnosis and have poor prognosis 3

Secretory Diarrheas:

• Congenital chloride diarrhea (CLD) - diagnosed by elevated stool chloride levels
• Congenital sodium diarrhea (CSD) - diagnosed by elevated stool sodium
• Treatment involves high-dose mineral replacement 3

Carbohydrate Malabsorption:

• Glucose-galactose malabsorption (GGM) - SLC5A1/SGLT1 gene mutations causing osmotic diarrhea from birth 4
• Lactose intolerance (congenital form)
• Sucrose-isomaltase deficiency
• Diagnosed by hydrogen breath tests; treated with elimination of offending sugars 3

Mineral Absorption Defects:

• Acrodermatitis enteropathica - zinc transporter defect with characteristic skin lesions and low serum zinc; responds to high-dose oral zinc 3
• Congenital hypomagnesemia

Inherited Disorders of Intestinal Lipid Metabolism

These disorders share common features: fat malabsorption, steatorrhea, failure to thrive, low plasma triglycerides and cholesterol, and fat-soluble vitamin deficiencies 5, 6:

• Abetalipoproteinemia - absence of microsomal triglyceride transfer protein (MTP), preventing chylomicron assembly
• Hypobetalipoproteinemia - apolipoprotein B gene defects
• Chylomicron retention disease (CMRD) - SAR1B gene mutations causing defective chylomicron secretion 7

Critical diagnostic clue: These patients present with hypocholesterolemia and hypotriglyceridemia, distinguishing them from other malabsorption causes. CMRD can present with isolated failure to gain weight without persistent diarrhea initially, making early genetic testing essential 7. Treatment requires low-fat diet with medium-chain triglyceride (MCT) supplementation and fat-soluble vitamins, with strict long-term adherence crucial to prevent neurodevelopmental complications 7.

MDR3 Deficiency (ABCB4 Gene)

Severe MDR3 deficiency causes moderate chronic cholestasis leading to growth failure, pruritus, fat-soluble vitamin deficiencies, and progression to biliary cirrhosis 8. Children require:

• Clinical and laboratory evaluation every 6 months
• Annual liver ultrasound
• Ursodeoxycholic acid (UDCA) therapy
• Nutritional support (oral, enteral, or parenteral)
• Liver transplantation consideration in end-stage disease 8

Diagnostic Approach

When evaluating an infant with failure to thrive and suspected malabsorption:

1. Rule out infectious, allergic, and anatomical causes first 2
2. Obtain newborn screening results - CF should be identified early
3. Assess stool characteristics:
   • Steatorrhea suggests pancreatic insufficiency (CF) or lipid transport defects
   • Watery diarrhea from birth suggests CODEs
   • Measure stool electrolytes (chloride, sodium) and pH
4. Check serum lipid panel - hypocholesterolemia/hypotriglyceridemia points to lipid transport disorders 5
5. Measure fecal pancreatic elastase-1 - <100 μg/g confirms pancreatic insufficiency 1
6. Consider hydrogen breath testing for carbohydrate malabsorption 3
7. Perform next-generation sequencing (NGS) early when clinical suspicion is high, as it identifies genetic mutations definitively 2, 7
8. Endoscopy with biopsies for histology and electron microscopy when structural enteropathies suspected 2

Critical Management Pitfall

The most common failure in managing these genetic disorders is inadequate long-term adherence to dietary restrictions and supplementation. As demonstrated in CMRD, even after initial improvement, poor compliance leads to recurrence of steatorrhea, persistent growth failure, and neurodevelopmental delay 7. Strict, sustained nutritional management with multidisciplinary follow-up is non-negotiable for optimal outcomes.